The clinical evidence shows most people stay on semaglutide for at least 68 weeks to achieve significant weight loss
Patients should maintain adequate hydration, especially during hot weather or illness, and should temporarily hold their medication during severe gastrointestinal illness to prevent volume depletion and acute kidney injury
Novo Nordisk already has an oral version of semaglutide, the active ingredient in Ozempic and Wegovy, on the market in Rybelsus, which was first approved in 2019, but that is indicated for treating Type 2 diabetes, not obesity
Pricing transparency: How does your PBM provide visibility into the true cost of medications (ingredient cost, dispensing fees, and PBM administrative fees) under a direct or pass-through pricing model
We're dedicated to providing you with the most up-to-date and science-backed ingredient info out there